KALA BIO (KALA) Short Interest Ratio & Short Volume → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free KALA Stock Alerts $6.55 -0.18 (-2.67%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability KALA BIO Short Interest DataCurrent Short Volume8,800 sharesPrevious Short Volume5,100 sharesChange Vs. Previous Month+72.55%Dollar Volume Sold Short$60,720.00Short Interest Ratio / Days to Cover0.5Last Record DateApril 30, 2024Outstanding Shares2,816,000 sharesFloat Size2,420,000 sharesShort Percent of Float0.36%Today's Trading Volume2,600 sharesAverage Trading Volume22,361 sharesToday's Volume Vs. Average12% Short Selling KALA BIO ? Sign up to receive the latest short interest report for KALA BIO and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatKALA Short Interest Over TimeKALA Days to Cover Over TimeKALA Percentage of Float Shorted Over Time Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. KALA BIO Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20248,800 shares $60,720.00 +72.6%0.4%0.5 $6.90 4/15/20245,100 shares $35,700.00 -15.0%0.2%0.2 $7.00 3/31/20246,000 shares $47,820.00 -50.4%0.3%0.2 $7.97 3/15/202412,100 shares $91,113.00 +22.2%0.5%0.4 $7.53 2/29/20249,900 shares $71,082.00 -18.2%0.4%0.2 $7.18 2/15/202412,100 shares $86,999.00 -28.4%0.5%0.1 $7.19 Get the Latest News and Ratings for KALA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for KALA BIO and its competitors with MarketBeat's FREE daily newsletter. 1/31/202416,900 shares $117,455.00 -50.2%0.8%0.2 $6.95 1/15/202433,900 shares $272,895.00 +20.2%1.6%0.4 $8.05 12/31/202328,200 shares $197,400.00 -61.6%1.4%0.4 $7.00 12/15/202373,500 shares $498,330.00 +34.9%3.4%1.1 $6.78 11/30/202354,500 shares $329,725.00 -14.0%2.6%0.8 $6.05 11/15/202363,400 shares $334,752.00 +0.2%3.0%3.6 $5.28 10/31/202363,300 shares $430,440.00 -15.8%3.2%3.3 $6.80 10/15/202375,200 shares $614,376.48 -24.8%3.8%3 $8.17 9/30/2023100,000 shares $890,000.00 +48.4%4.9%3.2 $8.90 9/15/202367,400 shares $716,462.00 +632.6%3.3%1.7 $10.63 8/31/20239,200 shares $123,464.00 -87.8%0.5%0.2 $13.42 8/15/202375,500 shares $1.03 million -18.6%3.8%1.2 $13.70 7/31/202392,800 shares $1.39 million -51.0%4.6%1.2 $15.03 7/15/2023189,400 shares $2.73 million -0.7%10.2%2.2 $14.43 6/30/2023190,800 shares $2.78 million +34.0%10.3%1.6 $14.59 6/15/2023142,400 shares $2.10 million -4.9%7.8%1 $14.73 5/31/2023149,800 shares $2.14 million -20.1%7.5%0.7 $14.30 5/15/2023187,500 shares $3.13 million +12.6%9.4%0.3 $16.67 4/30/2023166,500 shares $2.63 million -3.1%10.0%0.3 $15.77 4/15/2023171,900 shares $2.86 million -32.9%10.4%0.2 $16.63 3/31/2023256,200 shares $3.86 million +29.5%15.4%0.3 $15.05 3/15/2023197,800 shares $3.30 million -20.6%12.4%0.1 $16.69 2/28/2023249,100 shares $2.52 million +16.6%18.5%0.1 $10.13 2/15/2023213,600 shares $2.73 million -29.6%15.4%0.1 $12.78 1/31/2023303,200 shares $5.26 million +28.3%22.6%0.1 $17.34 1/15/2023236,300 shares $4.64 million -52.2%17.6%0.1 $19.62 12/30/2022494,700 shares $18.87 million +389.3%38.4%0.2 $38.15 12/15/2022101,100 shares $442,818.00 +5.4%7.8%0.5 $4.38 11/30/202295,900 shares $507,311.00 +25.2%7.5%0.5 $5.29 11/15/202276,600 shares $491,772.00 +74.5%6.0%0.5 $6.42 10/31/202243,900 shares $278,765.00 +32.6%3.9%0.3 $6.35 10/15/202233,100 shares $415,405.00 -97.9%N/A1.2 $12.55 9/30/20221,610,000 shares $356,454.00 -13.0%2.7%1.6 $0.22 9/15/20221,850,000 shares $626,780.00 -11.9%3.1%1.4 $0.3441 banks launch ‘crypto dollar’ (Ad)Everyone knows the US financial system is in the middle of a radical change... The White House wants an all-digital dollar. Plus at least 41 major banks (see if your bank is one of them right here).Here's how you capitalize (including #1 crypto to play it). KALA Short Interest - Frequently Asked Questions What is KALA BIO's current short interest? Short interest is the volume of KALA BIO shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 8,800 shares of KALA short. 0.36% of KALA BIO's shares are currently sold short. Learn More on KALA BIO's current short interest. What is a good short interest percentage for KALA BIO? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.36% of KALA BIO's floating shares are currently sold short. Is KALA BIO's short interest increasing or decreasing? KALA BIO saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 8,800 shares, an increase of 72.5% from the previous total of 5,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is KALA BIO's float size? KALA BIO currently has issued a total of 2,816,000 shares. Some of KALA BIO's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. KALA BIO currently has a public float of 2,420,000 shares. How does KALA BIO's short interest compare to its competitors? 0.36% of KALA BIO's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to KALA BIO: NeuroBo Pharmaceuticals, Inc. (2.06%), BioVie Inc. (3.18%), Cocrystal Pharma, Inc. (0.11%), Synlogic, Inc. (0.36%), Alaunos Therapeutics, Inc. (9.57%), Indaptus Therapeutics, Inc. (0.44%), Lumos Pharma, Inc. (6.09%), Sol-Gel Technologies Ltd. (0.04%), Orgenesis Inc. (0.84%), Aytu BioPharma, Inc. (7.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short KALA BIO stock? Short selling KALA is an investing strategy that aims to generate trading profit from KALA BIO as its price is falling. KALA shares are trading down $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against KALA BIO? A short squeeze for KALA BIO occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KALA, which in turn drives the price of the stock up even further. How often is KALA BIO's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KALA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: NeuroBo Pharmaceuticals Short Squeeze BioVie Short Squeeze Cocrystal Pharma Short Squeeze Synlogic Short Squeeze Alaunos Therapeutics Short Squeeze Indaptus Therapeutics Short Squeeze Lumos Pharma Short Squeeze Sol-Gel Technologies Short Squeeze Orgenesis Short Squeeze Aytu BioPharma Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KALA) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders